Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4)

Turk J Haematol. 2015 Jun;32(2):100-17. doi: 10.4274/tjh.2014.0277.

Abstract

This is the last of a series of articles on invasive fungal infections prepared by opinion leaders in Turkey. The aim of these articles is to guide clinicians in managing invasive fungal diseases in hematological malignancies and stem cell transplantation based on the available best evidence in this field. The previous articles summarized the diagnosis and treatment of invasive fungal disease and this article aims to explain the risk categorization and guide the antifungal prophylaxis in invasive fungal disease.

Bu makale Türkiye’de invazif fungal enfeksiyon ile uğraşan uzmanlar tarafından hazırlanan bir seri yazının sonuncusudur. Bu makaleler hematolojik malignitelerde ve kök hücre nakli hastalarında invazif fungal hastalıkların yönetimini eldeki kanıtların ışığında en iyi hale getirmeyi amaçlamaktadır. İlk yazılar tanı ve tedaviyi özetlerken, bu makale invazif fungal hastalıkta risk kategorizasyonu ve profilaksiyi ele almaktadır.

Publication types

  • Review

MeSH terms

  • Antifungal Agents / blood
  • Antifungal Agents / therapeutic use
  • Antineoplastic Agents / adverse effects
  • Cross Infection / etiology
  • Cross Infection / prevention & control
  • Disinfection / methods
  • Febrile Neutropenia / chemically induced
  • Febrile Neutropenia / complications
  • Hematologic Neoplasms / complications*
  • Hematologic Neoplasms / drug therapy
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Invasive Fungal Infections / etiology
  • Invasive Fungal Infections / prevention & control*
  • Opportunistic Infections / etiology
  • Opportunistic Infections / prevention & control*
  • Practice Guidelines as Topic
  • Risk Assessment
  • Secondary Prevention
  • Transplantation Conditioning / adverse effects

Substances

  • Antifungal Agents
  • Antineoplastic Agents
  • Immunosuppressive Agents